You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 15, 2024

Teva Parenteral Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for TEVA PARENTERAL, and what generic and branded alternatives to TEVA PARENTERAL drugs are available?

TEVA PARENTERAL has forty-seven approved drugs.

There are six tentative approvals on TEVA PARENTERAL drugs.

Summary for Teva Parenteral

US Patents:	0
Tradenames:	39
Ingredients:	37
NDAs:	47

Drugs and US Patents for Teva Parenteral

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Teva Parenteral	ADRUCIL	fluorouracil	INJECTABLE;INJECTION	081225-001	Aug 28, 1991		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Teva Parenteral	DAUNORUBICIN HYDROCHLORIDE	daunorubicin hydrochloride	INJECTABLE;INJECTION	064212-002	May 3, 1999		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Teva Parenteral	BRIMONIDINE TARTRATE	brimonidine tartrate	SOLUTION/DROPS;OPHTHALMIC	076372-001	Sep 10, 2004		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Teva Parenteral	SUMATRIPTAN SUCCINATE	sumatriptan succinate	INJECTABLE;SUBCUTANEOUS	078318-001	Feb 6, 2009		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Teva Parenteral	HYDRALAZINE HYDROCHLORIDE	hydralazine hydrochloride	INJECTABLE;INJECTION	040373-001	Feb 23, 2000		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Teva Parenteral	BLEOMYCIN SULFATE	bleomycin sulfate	INJECTABLE;INJECTION	064084-001	Jun 1, 1996		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Teva Parenteral	ATRACURIUM BESYLATE	atracurium besylate	INJECTABLE;INJECTION	074784-001	Jun 11, 1997		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Teva Parenteral

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Teva Parenteral	CYTARABINE	cytarabine	INJECTABLE;INJECTION	016793-001	Approved Prior to Jan 1, 1982	3,444,294	⤷ Sign Up
Teva Parenteral	CYTARABINE	cytarabine	INJECTABLE;INJECTION	016793-002	Approved Prior to Jan 1, 1982	3,444,294	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.